Back to Directory
Xgenera
South East England
Founded 2023
Blood-based microRNA test for multi-cancer early detection
Xgenera is a diagnostics company developing a blood test for the early detection of multiple cancers from a single sample.
The test measures circulating microRNA biomarkers using PCR-based methods and applies machine learning to identify signals from up to 12 common cancers before symptoms appear.
The company is running clinical studies to evaluate the test, with the aim of supporting earlier cancer diagnosis in healthcare screening and diagnostic pathways.